James E. Dentzer

Insider Reports History

Entity
Individual
Location
C/O Amicus Therapeutics, Inc., 6 Cedar Brook Drive, Cranbury, NJ
Signature
/s/ Kimberly Graper, VP of Finance & Controller
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James E. Dentzer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CURIS INC President & CEO, Director Employee stock option (right to buy) 100K $1.16M $11.62 May 21, 2024 Direct
Imunon, Inc. Director Stock Option (Right to Buy) 17.3K Sep 6, 2024 Direct

Insider Reports Filed by James E. Dentzer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IMNN Imunon, Inc. Sep 10, 2024 1 $0 4 Sep 10, 2024 Director
IMNN Imunon, Inc. Jun 12, 2024 1 $0 4 Jun 14, 2024 Director
CRIS CURIS INC May 21, 2024 1 $1.16M 4 May 23, 2024 President & CEO, Director
IMNN Imunon, Inc. Mar 15, 2024 1 $0 4 Mar 18, 2024 Director
IMNN Imunon, Inc. Mar 17, 2023 1 $0 4 Mar 21, 2023 Director
CRIS CURIS INC Jan 20, 2023 1 $0 4 Jan 24, 2023 President & CEO, Director
IMNN Imunon, Inc. Sep 30, 2022 1 $0 4 Oct 3, 2022 Director
IMNN Imunon, Inc. Sep 29, 2022 0 $0 3 Oct 3, 2022 Director
CRIS CURIS INC Jan 27, 2022 3 -$17.1K 4 Jan 31, 2022 President & CEO, Director